deltatrials
Unknown OBSERVATIONAL NCT03664648

DV2-HBV-27: Observational Pregnancy Registry (HBV-27)

HEPLISAV-B Pregnancy Registry: An Observational Study on the Safety of HEPLISAV-B Exposure in Pregnant Women and Their Offspring

Sponsor: Dynavax Technologies Corporation

Conditions Pregnant
Interventions HEPLISAV-B
Updated 11 times since 2018 Last updated: Sep 15, 2023 Started: Feb 21, 2021 Primary completion: Sep 30, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pregnant, this trial is ongoing. The trial is conducted by Dynavax Technologies Corporation and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Oct 2018 – ~Aug 2019 · 10 months · monthly snapshotRecruiting~Aug 2019 – ~Apr 2020 · 8 months · monthly snapshotRecruiting~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshotRecruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotRecruiting~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshotRecruiting~Mar 2021 – ~May 2022 · 14 months · monthly snapshotRecruiting~May 2022 – ~Oct 2023 · 17 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Nov 2025 · 14 months · monthly snapshotActive Not Recruiting~Nov 2025 – present · 9 months · monthly snapshotUnknown

Change History

11 versions recorded

  1. Nov 2025 — Present [monthly]

    Unknown

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Nov 2025 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  5. May 2022 — Oct 2023 [monthly]

    Recruiting

▶ Show 6 earlier versions

  1. Mar 2021 — May 2022 [monthly]

    Recruiting

  2. Jan 2021 — Mar 2021 [monthly]

    Recruiting

  3. Oct 2020 — Jan 2021 [monthly]

    Recruiting

  4. Apr 2020 — Oct 2020 [monthly]

    Recruiting

  5. Aug 2019 — Apr 2020 [monthly]

    Recruiting

  6. Oct 2018 — Aug 2019 [monthly]

    Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dynavax Technologies Corporation
  • PPD, Part of Thermo Fisher Scientific
Data source: Dynavax Technologies Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations